Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Drug Safety|January 11, 2016
Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous DatabasesSuzie Seabroke, Gianmario Candore, Kristina Juhlin, et al.
Pharmacoepidemiology and Drug Safety|December 27, 2017
Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?Alexandra C Pacurariu, Christina E Hoeve, Peter Arlett, et al.
Clinical Pharmacology and Therapeutics|April 4, 2020
Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European ModelRona Gini, Miriam C J Sturkenboom, Janet Sultana, et al.
Drug Safety|March 9, 2016
Good Signal Detection Practices: Evidence from IMI PROTECTAntoni F Z Wisniewski, Andrew Bate, Cedric Bousquet, et al.
Plos One|February 24, 2015
Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database studyMarietta Rottenkolber, Eef Voogd, Liset van Dijk, et al.
Epilepsia|March 1, 2014
Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparisonMark C H de Groot, Markus Schuerch, Frank de Vries, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2015
Prevalence of antibiotic use: a comparison across various European health care data sourcesRuth Brauer, Ana Ruigómez, Gerry Downey, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fracturesPatrick C Souverein, Victoria Abbing-Karahagopian, Elisa Martin, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2015
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU ProjectConsuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, et al.
Pageof 4